Financhill
Sell
8

NUWE Quote, Financials, Valuation and Earnings

Last price:
$15.35
Seasonality move :
-15.57%
Day range:
$6.35 - $7.56
52-week range:
$6.33 - $196.98
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.89x
P/B ratio:
13.40x
Volume:
1.2M
Avg. volume:
582.6K
1-year change:
-96.12%
Market cap:
$48M
Revenue:
$8.7M
EPS (TTM):
-$18.24

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
NUWE
Nuwellis
$2.2M -- 0.27% -- $13.00
ELMD
Electromed
$16.4M -- 12.26% -- $33.50
HOLX
Hologic
$1B $1.05 -0.54% 28.19% $69.34
QTRX
Quanterix
$30.3M -$0.69 -10.47% -- $11.25
RSLS
Reshape Lifesciences
$2.1M -$9.28 -- -- --
VREX
Varex Imaging
$190.3M $0.04 -8.98% 16.67% $16.60
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
NUWE
Nuwellis
$6.90 $13.00 $48M -- $0.00 0% 0.89x
ELMD
Electromed
$18.24 $33.50 $153M 23.09x $0.00 0% 2.66x
HOLX
Hologic
$63.26 $69.34 $14.1B 26.69x $0.00 0% 3.65x
QTRX
Quanterix
$5.49 $11.25 $213.2M -- $0.00 0% 1.58x
RSLS
Reshape Lifesciences
$2.68 -- $2M 0.01x $0.00 0% 0.01x
VREX
Varex Imaging
$7.73 $16.60 $320.9M 17.58x $0.00 0% 0.41x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
NUWE
Nuwellis
-- -2.772 -- 1.49x
ELMD
Electromed
-- 2.259 -- 4.79x
HOLX
Hologic
35.28% 0.986 18.29% 2.29x
QTRX
Quanterix
-- 1.424 -- 7.31x
RSLS
Reshape Lifesciences
-- 1.926 -- 0.79x
VREX
Varex Imaging
50.78% 1.879 115.17% 2.18x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
NUWE
Nuwellis
$1.1M -$3.1M -670.55% -670.55% -160.71% -$2.5M
ELMD
Electromed
$12.2M $2.1M 16.57% 16.57% 13.65% $2.2M
HOLX
Hologic
$377.3M $37.9M 7.53% 11.45% 0.06% $129.2M
QTRX
Quanterix
$16.4M -$26.4M -14.39% -14.39% -87.09% -$15.1M
RSLS
Reshape Lifesciences
$681K -$1.8M -159.67% -172.58% -165.23% -$2.1M
VREX
Varex Imaging
$76.7M $22.1M -3.95% -7.36% 9.49% $9.8M

Nuwellis vs. Competitors

  • Which has Higher Returns NUWE or ELMD?

    Electromed has a net margin of -158.3% compared to Nuwellis's net margin of 12.06%. Nuwellis's return on equity of -670.55% beat Electromed's return on equity of 16.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    NUWE
    Nuwellis
    56.04% -$0.69 $3.6M
    ELMD
    Electromed
    77.97% $0.21 $43.9M
  • What do Analysts Say About NUWE or ELMD?

    Nuwellis has a consensus price target of $13.00, signalling upside risk potential of 6600.51%. On the other hand Electromed has an analysts' consensus of $33.50 which suggests that it could grow by 83.66%. Given that Nuwellis has higher upside potential than Electromed, analysts believe Nuwellis is more attractive than Electromed.

    Company Buy Ratings Hold Ratings Sell Ratings
    NUWE
    Nuwellis
    0 0 0
    ELMD
    Electromed
    2 0 0
  • Is NUWE or ELMD More Risky?

    Nuwellis has a beta of 0.281, which suggesting that the stock is 71.882% less volatile than S&P 500. In comparison Electromed has a beta of 0.413, suggesting its less volatile than the S&P 500 by 58.696%.

  • Which is a Better Dividend Stock NUWE or ELMD?

    Nuwellis has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nuwellis pays -- of its earnings as a dividend. Electromed pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NUWE or ELMD?

    Nuwellis quarterly revenues are $1.9M, which are smaller than Electromed quarterly revenues of $15.7M. Nuwellis's net income of -$3M is lower than Electromed's net income of $1.9M. Notably, Nuwellis's price-to-earnings ratio is -- while Electromed's PE ratio is 23.09x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nuwellis is 0.89x versus 2.66x for Electromed. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NUWE
    Nuwellis
    0.89x -- $1.9M -$3M
    ELMD
    Electromed
    2.66x 23.09x $15.7M $1.9M
  • Which has Higher Returns NUWE or HOLX?

    Hologic has a net margin of -158.3% compared to Nuwellis's net margin of -1.73%. Nuwellis's return on equity of -670.55% beat Hologic's return on equity of 11.45%.

    Company Gross Margin Earnings Per Share Invested Capital
    NUWE
    Nuwellis
    56.04% -$0.69 $3.6M
    HOLX
    Hologic
    37.53% -$0.08 $7.1B
  • What do Analysts Say About NUWE or HOLX?

    Nuwellis has a consensus price target of $13.00, signalling upside risk potential of 6600.51%. On the other hand Hologic has an analysts' consensus of $69.34 which suggests that it could grow by 9.61%. Given that Nuwellis has higher upside potential than Hologic, analysts believe Nuwellis is more attractive than Hologic.

    Company Buy Ratings Hold Ratings Sell Ratings
    NUWE
    Nuwellis
    0 0 0
    HOLX
    Hologic
    4 13 0
  • Is NUWE or HOLX More Risky?

    Nuwellis has a beta of 0.281, which suggesting that the stock is 71.882% less volatile than S&P 500. In comparison Hologic has a beta of 0.553, suggesting its less volatile than the S&P 500 by 44.736%.

  • Which is a Better Dividend Stock NUWE or HOLX?

    Nuwellis has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Hologic offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nuwellis pays -- of its earnings as a dividend. Hologic pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NUWE or HOLX?

    Nuwellis quarterly revenues are $1.9M, which are smaller than Hologic quarterly revenues of $1B. Nuwellis's net income of -$3M is higher than Hologic's net income of -$17.4M. Notably, Nuwellis's price-to-earnings ratio is -- while Hologic's PE ratio is 26.69x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nuwellis is 0.89x versus 3.65x for Hologic. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NUWE
    Nuwellis
    0.89x -- $1.9M -$3M
    HOLX
    Hologic
    3.65x 26.69x $1B -$17.4M
  • Which has Higher Returns NUWE or QTRX?

    Quanterix has a net margin of -158.3% compared to Nuwellis's net margin of -67.73%. Nuwellis's return on equity of -670.55% beat Quanterix's return on equity of -14.39%.

    Company Gross Margin Earnings Per Share Invested Capital
    NUWE
    Nuwellis
    56.04% -$0.69 $3.6M
    QTRX
    Quanterix
    54.03% -$0.53 $316.4M
  • What do Analysts Say About NUWE or QTRX?

    Nuwellis has a consensus price target of $13.00, signalling upside risk potential of 6600.51%. On the other hand Quanterix has an analysts' consensus of $11.25 which suggests that it could grow by 104.92%. Given that Nuwellis has higher upside potential than Quanterix, analysts believe Nuwellis is more attractive than Quanterix.

    Company Buy Ratings Hold Ratings Sell Ratings
    NUWE
    Nuwellis
    0 0 0
    QTRX
    Quanterix
    1 2 0
  • Is NUWE or QTRX More Risky?

    Nuwellis has a beta of 0.281, which suggesting that the stock is 71.882% less volatile than S&P 500. In comparison Quanterix has a beta of 1.127, suggesting its more volatile than the S&P 500 by 12.667%.

  • Which is a Better Dividend Stock NUWE or QTRX?

    Nuwellis has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quanterix offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nuwellis pays -- of its earnings as a dividend. Quanterix pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NUWE or QTRX?

    Nuwellis quarterly revenues are $1.9M, which are smaller than Quanterix quarterly revenues of $30.3M. Nuwellis's net income of -$3M is higher than Quanterix's net income of -$20.5M. Notably, Nuwellis's price-to-earnings ratio is -- while Quanterix's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nuwellis is 0.89x versus 1.58x for Quanterix. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NUWE
    Nuwellis
    0.89x -- $1.9M -$3M
    QTRX
    Quanterix
    1.58x -- $30.3M -$20.5M
  • Which has Higher Returns NUWE or RSLS?

    Reshape Lifesciences has a net margin of -158.3% compared to Nuwellis's net margin of -68.98%. Nuwellis's return on equity of -670.55% beat Reshape Lifesciences's return on equity of -172.58%.

    Company Gross Margin Earnings Per Share Invested Capital
    NUWE
    Nuwellis
    56.04% -$0.69 $3.6M
    RSLS
    Reshape Lifesciences
    61.19% $474.50 $1.2M
  • What do Analysts Say About NUWE or RSLS?

    Nuwellis has a consensus price target of $13.00, signalling upside risk potential of 6600.51%. On the other hand Reshape Lifesciences has an analysts' consensus of -- which suggests that it could grow by 54004.41%. Given that Reshape Lifesciences has higher upside potential than Nuwellis, analysts believe Reshape Lifesciences is more attractive than Nuwellis.

    Company Buy Ratings Hold Ratings Sell Ratings
    NUWE
    Nuwellis
    0 0 0
    RSLS
    Reshape Lifesciences
    0 0 0
  • Is NUWE or RSLS More Risky?

    Nuwellis has a beta of 0.281, which suggesting that the stock is 71.882% less volatile than S&P 500. In comparison Reshape Lifesciences has a beta of 1.166, suggesting its more volatile than the S&P 500 by 16.59%.

  • Which is a Better Dividend Stock NUWE or RSLS?

    Nuwellis has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Reshape Lifesciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nuwellis pays -- of its earnings as a dividend. Reshape Lifesciences pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NUWE or RSLS?

    Nuwellis quarterly revenues are $1.9M, which are larger than Reshape Lifesciences quarterly revenues of $1.1M. Nuwellis's net income of -$3M is lower than Reshape Lifesciences's net income of $1.5M. Notably, Nuwellis's price-to-earnings ratio is -- while Reshape Lifesciences's PE ratio is 0.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nuwellis is 0.89x versus 0.01x for Reshape Lifesciences. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NUWE
    Nuwellis
    0.89x -- $1.9M -$3M
    RSLS
    Reshape Lifesciences
    0.01x 0.01x $1.1M $1.5M
  • Which has Higher Returns NUWE or VREX?

    Varex Imaging has a net margin of -158.3% compared to Nuwellis's net margin of 3.24%. Nuwellis's return on equity of -670.55% beat Varex Imaging's return on equity of -7.36%.

    Company Gross Margin Earnings Per Share Invested Capital
    NUWE
    Nuwellis
    56.04% -$0.69 $3.6M
    VREX
    Varex Imaging
    36.03% $0.17 $1.1B
  • What do Analysts Say About NUWE or VREX?

    Nuwellis has a consensus price target of $13.00, signalling upside risk potential of 6600.51%. On the other hand Varex Imaging has an analysts' consensus of $16.60 which suggests that it could grow by 114.75%. Given that Nuwellis has higher upside potential than Varex Imaging, analysts believe Nuwellis is more attractive than Varex Imaging.

    Company Buy Ratings Hold Ratings Sell Ratings
    NUWE
    Nuwellis
    0 0 0
    VREX
    Varex Imaging
    3 1 0
  • Is NUWE or VREX More Risky?

    Nuwellis has a beta of 0.281, which suggesting that the stock is 71.882% less volatile than S&P 500. In comparison Varex Imaging has a beta of 0.697, suggesting its less volatile than the S&P 500 by 30.263%.

  • Which is a Better Dividend Stock NUWE or VREX?

    Nuwellis has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Varex Imaging offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nuwellis pays -- of its earnings as a dividend. Varex Imaging pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios NUWE or VREX?

    Nuwellis quarterly revenues are $1.9M, which are smaller than Varex Imaging quarterly revenues of $212.9M. Nuwellis's net income of -$3M is lower than Varex Imaging's net income of $6.9M. Notably, Nuwellis's price-to-earnings ratio is -- while Varex Imaging's PE ratio is 17.58x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nuwellis is 0.89x versus 0.41x for Varex Imaging. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    NUWE
    Nuwellis
    0.89x -- $1.9M -$3M
    VREX
    Varex Imaging
    0.41x 17.58x $212.9M $6.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Can SharkNinja Stock Go?
How High Can SharkNinja Stock Go?

If you know popular consumer appliance brands Shark and Ninja,…

Will Oklo Stock Double?
Will Oklo Stock Double?

Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…

Why a $5 Stock Is Suddenly a Cash Machine
Why a $5 Stock Is Suddenly a Cash Machine

If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…

Stock Ideas

Buy
71
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 58x

Buy
61
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
78
SBET alert for Jul 16

SharpLink Gaming [SBET] is up 23.89% over the past day.

Buy
75
MP alert for Jul 16

MP Materials [MP] is down 1.13% over the past day.

Sell
38
NAIL alert for Jul 16

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 0.76% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock